Methodological approaches and use of multiple criteria decision analysis for implementation of National Drug Policy in Ukraine

Abstract

In many developed countries, the needs of the population in health protection technology exceeds government financing of health care system. Actually, there are no common models for funding priorities in health care system. To remain a major fields for financing is a serious task for health experts all over the world. Aim. To develop an algorithm, methodological approaches and stages of multiple criteria decision analysis (MCDA) in Ukraine; to systematize and substantiate the criteria selec-tion, criteria weights and their calculation on the example of innovative medicines in the treatment of oncology and orphan diseases for the efficient use of health care resources in the implementation of the State strategy of National Drug Policy for the period up to 2025. Results. In this paper we used method of systematization, that in practice of developed countries for health technology assessment (HTA) MCDA started to be implemented in practice, in particular by HTA agencies. The main core clusters of criteria that are basis for use in MCDA models in Ukraine are substantiated and proposed: 1) therapeutic effect and safety; 2) economics; 3) social and ethical factors; 4) disease description, acknowl-edging that MCDA models should always be adapted to the decision problem and the local settings (epidemiological, statistical data and needs of the national health system). The algorithm, stages and human capital for MCDA in Ukraine were considered and sys-tematized based on the data of ISPOR and LSE guidelines: problem structuring, devel-opment of the local MCDA model, evaluation, validation, report and elaboration of an action plan on the example of oncology and orphan diseases. We have analysed criteria weights for selection of medicines for the treatment of oncology and orphan diseases based on case studies with experts who are decision makers on medicines procurement. The findings indicate the presence of different value judgements of the importance of criteria in case studies using specially designed questionnaires. The results were processed using the Microsoft Excel software package. It has been established that the two criteria – therapeutic effect and costs were of the highest importance for experts involved in deci-sion-making in financing and the innovation is less relevant in determining procurement priorities. Conclusions. The MCDA for medical insurance widely used by HTA the agencies worldwide was outlined in our article. Results of the case studies conducted in Ukraine showed that MCDA is an effective and promising tool for scientifically substantiated, transparent decision-making on reimbursement, drug program financing, insurance provi-sion, in particular innovative high-priced medicines with the purpose of rational allocation of resources for pharmaceutical assistance to the population in accordance with the objec-tives of the National Drug Policy implementation for the period up to 2025.

Authors and Affiliations

O. B. Piniazhko, O. M. Zaliska

Keywords

Related Articles

Theoretical and methodological approaches to development of the “road map” for promoting a new medicine product to the pharmaceutical market

The aim of the article is to develop theoretical and methodological approaches to composing the “road map” to promote a new medicine product (МР) to the market. The methodological basis of the research is the statements...

Міжнародний механізм протидії фальсифікації медичної продукції як засіб підвищення якості у фармації України

Метою роботи є вироблення рекомендацій щодо вдосконалення в Україні організації протидії фальсифікації медичної продукції з використанням міжнародного механізму такої протидії, що має привести до підвищення якості у фарм...

Разработка состава и технологии комбинированного геля с растительными экстрактами

Целью работы стало экспериментальное обоснование технологического режима изготовления гелевой основы и введение в нее солюбилизатора, метилсалицилата и растительных экстрактов листьев шалфея лекарственного и коры ивы бел...

Анализ современных подходов к предупреждению антимикробной резистентности: роль и место физико-химических методов исследований in vitro и оценки биоэквивалентности

Проблема антимикробной резистентности является одним из ключевых вызовов в современном мире. Глобальный анализ ситуации с развитием резистентности к антибактериальным препаратам показал, что решение этой задачи требует р...

Аналіз факторів ризику забруднення механічними включеннями лабораторних серій препарату «Ніавіт, розчин для ін’єкцій» на етапі фармацевтичної розробки

Мета. Вивчення за допомогою діаграми Ішикави одного з інструментів управління ризиками, потенційних факторів ризику на етапі фармацевтичної розробки (ФР), що впливають на якість ін’єкційного лікарського препарату (ЛП) Ні...

Download PDF file
  • EP ID EP659402
  • DOI 10.24959/uekj.19.9
  • Views 183
  • Downloads 0

How To Cite

O. B. Piniazhko, O. M. Zaliska (2019). Methodological approaches and use of multiple criteria decision analysis for implementation of National Drug Policy in Ukraine. Управління, економіка та забезпечення якості в фармації, 1(57), 60-66. https://europub.co.uk/articles/-A-659402